Article

The Novo Nordisk Foundation is investing 5.5 billion Danish kroner ($860 million) in Copenhagen's BioInnovation Institute (BII) to enhance the growth of local biotech and deep tech companies. Established in 2018, BII has already helped create over 130 companies and attracted 7 billion kroner ($1.09 billion) in external funding, with the new investment aimed at bolstering innovation and addressing health challenges in Europe through 2035.